Prepair 500+
Gene: CLN3Comment when marking as ready: Downgrade to Amber until CNV analysis included.Created: 24 Apr 2025, 3:09 p.m. | Last Modified: 24 Apr 2025, 3:09 p.m.
Panel Version: 1.2085
Comment when marking as ready: Consider exclusion (Amber) as we will miss a high proportion of cases due to the founder variant being a 1kb deletionCreated: 3 Apr 2025, 12:14 p.m. | Last Modified: 3 Apr 2025, 12:14 p.m.
Panel Version: 1.1822
Well established gene disease association.
Severe neurodegenerative disorder.
HGNC approved symbol/name: CLN3
Is the phenotype(s) severe and onset <18yo ? Y
Known technical challenges? Y, founder variant for Batten disease in CLN3 is a 1.02 kb deletion estimated to account for ~75-95% of pathogenic variants, 90% in Finland.
Gene reported in >3 independent familiesCreated: 18 Nov 2024, 12:18 p.m. | Last Modified: 18 Nov 2024, 12:18 p.m.
Panel Version: 1.547
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Ceroid lipofuscinosis, neuronal, 3, MIM# 204200; MONDO:0008767
Publications
Gene: cln3 has been classified as Amber List (Moderate Evidence).
Phenotypes for gene: CLN3 were changed from Ceroid lipofuscinosis, neuronal, 3, 204200 (3) to Ceroid lipofuscinosis, neuronal, 3, MIM# 204200; MONDO:0008767
Publications for gene: CLN3 were set to
Gene: cln3 has been classified as Amber List (Moderate Evidence).
gene: CLN3 was added gene: CLN3 was added to Prepair 500+. Sources: Mackenzie's Mission,Expert Review Green Mode of inheritance for gene: CLN3 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: CLN3 were set to Ceroid lipofuscinosis, neuronal, 3, 204200 (3)